文献速递脑血管病

REGARDS研究中血浆代谢物与Life's Simple 7的关系

Plasma Metabolites and Life's Simple 7 in REGARDS.
PubMed 文献 · Stroke · 2024-03-14

本研究在REGARDS研究的卒中病例-队列中,采用靶向代谢组学检测162种血浆代谢物,分析其与Life's Simple 7(LS7)评分及缺血性卒中的关联与中介效应。发现鸟苷、可替宁和乙酰神经氨酸与LS7评分及缺血性卒中相关,并部分中介LS7与缺血性卒中的关系。

要点

  • 鸟苷、可替宁和乙酰神经氨酸与LS7评分呈负相关。
  • 鸟苷、可替宁和乙酰神经氨酸与缺血性卒中风险升高相关。
  • 上述三种代谢物部分中介LS7与缺血性卒中的关系。

核心结论

  • 研究识别出鸟苷、可替宁和乙酰神经氨酸与LS7评分、缺血性卒中相关,并中介LS7与缺血性卒中的关系。

研究设计与样本

  • 在REGARDS研究(卒中地理与种族差异原因研究)中嵌套的卒中病例-队列,采用液相色谱-串联质谱对162种代谢物进行靶向代谢组学检测。
  • 研究包含1075例缺血性卒中病例和随机队列样本中的968名参与者。
  • 采用加权线性回归和加权Cox比例风险模型分别识别与LS7和缺血性卒中相关的代谢物,效应量基于代谢物水平1个标准差的变化。
  • 采用逆比值比加权中介分析检验代谢物的中介效应。

主要发现

  • 162种代谢物中有3种与总体LS7评分相关:鸟苷(β=-0.46,95%CI -0.65至-0.27,P=2.87×10⁻⁶)、可替宁(β=-0.49,95%CI -0.70至-0.28,P=7.74×10⁻⁶)和乙酰神经氨酸(β=-0.59,95%CI -0.77至-0.42,P=4.29×10⁻¹¹)。
  • 鸟苷(HR=1.47,95%CI 1.31-1.65,P=6.97×10⁻¹¹)、可替宁(HR=1.30,95%CI 1.16-1.44,P=2.09×10⁻⁶)和乙酰神经氨酸(HR=1.29,95%CI 1.15-1.45,P=9.24×10⁻⁶)与缺血性卒中发生相关。
  • 中介分析显示鸟苷(中介比例27%,间接效应P=0.002)、可替宁(中介比例30%,间接效应P=0.004)和乙酰神经氨酸(中介比例22%,间接效应P=0.041)部分中介了LS7与缺血性卒中的关系。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The American Heart Association's Life's Simple 7 (LS7) is a health metric that captures important factors associated with cardiovascular and cerebrovascular health. Previous studies highlight the potential of plasma metabolites to serve as a marker for lifestyle and health behavior that could be a target for stroke prevention. The objectives of this study were to identify metabolites that were associated with LS7 and incident ischemic stroke and mediate the relationship between the two. METHODS: Targeted metabolomic profiling of 162 metabolites by liquid chromatography-tandem mass spectrometry was used to identify candidate metabolites in a stroke case-cohort nested within the REGARDS study (Reasons for Geographic and Racial Differences in Stroke). Weighted linear regression and weighted Cox proportional hazard models were used to identify metabolites that were associated with LS7 and incident ischemic stroke, respectively. Effect measures were based on a 1-SD change in metabolite level. Metabolite mediators were examined using inverse odds ratio weighting mediation analysis. RESULTS: The study comprised 1075 ischemic stroke cases and 968 participants in the random cohort sample. Three out of 162 metabolites were associated with the overall LS7 score including guanosine (β, -0.46 [95% CI, -0.65 to -0.27]; P=2.87×10-6), cotinine (β, -0.49 [95% CI, -0.70 to -0.28]; P=7.74×10-6), and acetylneuraminic acid (β, -0.59 [95% CI, -0.77 to -0.42]; P=4.29×10-11). Guanosine (hazard ratio, 1.47 [95% CI, 1.31-1.65]; P=6.97×10-11), cotinine (hazard ratio, 1.30 [95% CI, 1.16-1.44]; P=2.09×10-6), and acetylneuraminic acid (hazard ratio, 1.29 [95% CI, 1.15-1.45]; P=9.24×10-6) were associated with incident ischemic stroke. The mediation analysis identified guanosine (27% mediation, indirect effect; P=0.002), cotinine (30% mediation, indirect effect; P=0.004), and acetylneurminic acid (22% mediation, indirect effect; P=0.041) partially mediated the relationship between LS7 and ischemic stroke. CONCLUSIONS: We identified guanosine, cotinine, and acetylneuraminic acid that were associated with LS7, incident ischemic stroke, and mediated the relationship between LS7 and ischemic stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Kijpaisalratana N, Ament Z, Patki A, et al. Plasma Metabolites and Life's Simple 7 in REGARDS. Stroke. 2024. PMID: 38482689. doi:10.1161/STROKEAHA.123.044714

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。